Literature DB >> 8444939

Bone-marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression.

S Hofmann1, A Engel, A Neuhold, K Leder, J Kramer, H Plenk.   

Abstract

Bone-marrow oedema syndrome (BMOS) of the hip gives a characteristic MRI pattern, in association with severe pain, non-specific focal loss of radiological density and a positive bone scan. In our MRI-controlled study, nine patients with non-traumatic BMOS in ten hips all had core decompression. Bone-marrow pressure measurements and intraosseous venography in five cases showed pathological values. All patients had immediate relief of pain, with return of MRI signals to normal after three months. Regular review was continued for at least 24 months with serial clinical radiological and MRI assessment. At a mean follow-up of 33 months all patients remained free of pain with normal radiographs and MR scans. The histological evaluation of undecalcified sections obtained from eight core decompressions confirmed the presence of bone-marrow oedema, with necrotic and reparative processes involving bone and marrow similar to those of early avascular necrosis but with no evidence of 'osteoporosis'. These findings support the assumption that BMOS may be the initial phase of non-traumatic avascular necrosis. In most patients BMOS will have a self-limiting course, but the duration of symptoms may be reduced by core decompression treatment.

Entities:  

Mesh:

Year:  1993        PMID: 8444939

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  40 in total

1.  Transient bone marrow edema syndrome progressing to avascular necrosis of the hip - a case report and review of the literature.

Authors:  S Radke; W Kenn; J Eulert
Journal:  Clin Rheumatol       Date:  2003-12-19       Impact factor: 2.980

2.  Schmorl's nodes and low-back pain. Analysis of magnetic resonance imaging findings in symptomatic and asymptomatic individuals.

Authors:  K Takahashi; T Miyazaki; H Ohnari; T Takino; K Tomita
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

3.  Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle.

Authors:  Eric Röhner; Timo Zippelius; David Steindl; Jasmin Fussi; Carsten Perka
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-19

Review 4.  [Femoral head necrosis].

Authors:  J Kramer; G Scheurecker; A Scheurecker; A Stöger; A Huber; S Hofmann
Journal:  Radiologe       Date:  2009-05       Impact factor: 0.635

5.  Regional migratory osteoporosis: case report of a patient with neuropathic pain.

Authors:  Esin Kartal; Ebru Sahin; Banu Dilek; Meltem Baydar; Metin Manisali; Can Kosay; Selmin Gulbahar
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

6.  Effectiveness of extracorporeal shock wave therapy in bone marrow edema syndrome of the hip.

Authors:  Cristina d'Agostino; Pietro Romeo; Vito Lavanga; Salvatore Pisani; Valerio Sansone
Journal:  Rheumatol Int       Date:  2014-11       Impact factor: 2.631

7.  Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost.

Authors:  Roland Meizer; Dominik Meraner; Elisabeth Meizer; Christian Radda; Franz Landsiedl; Nicolas Aigner
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

8.  Risk factors in transient osteoporosis: a retrospective study on 23 cases.

Authors:  Carlo Trevisan; Raymond Klumpp; Riccardo Compagnoni
Journal:  Clin Rheumatol       Date:  2016-03-16       Impact factor: 2.980

9.  Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology.

Authors:  Mihra S Taljanovic; Anna R Graham; James B Benjamin; Arthur F Gmitro; Elizabeth A Krupinski; Stephanie A Schwartz; Tim B Hunter; Donald L Resnick
Journal:  Skeletal Radiol       Date:  2008-02-15       Impact factor: 2.199

Review 10.  Bone marrow edema syndrome.

Authors:  Anastasios V Korompilias; Apostolos H Karantanas; Marios G Lykissas; Alexandros E Beris
Journal:  Skeletal Radiol       Date:  2008-07-16       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.